Mdc Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 12.24 Cr
- Company Age 30 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 34.65 Cr
- Satisfied Charges ₹ 44.98 Cr
- Revenue Growth 18.24%
- Profit Growth 43.26%
- Ebitda 10.04%
- Net Worth 9.04%
- Total Assets 10.40%
About Mdc Pharmaceuticals
Mdc Pharmaceuticals Limited (MPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 14 July 1994 and has a history of 30 years and seven months. Its registered office is in Chandigarh, India.
The Corporate was formerly known as Mdc Pharmaceuticals Pvt Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 12.24 Cr.
The company currently has active open charges totaling ₹34.65 Cr. The company has closed loans amounting to ₹44.98 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Mdc Pharmaceuticals Limited India are Jolly Kashyap as COMPANY SECRETARY and Pramila Devi as Cfo. Vir Singh, Jatinder Wig, Manisha Sharma, and Five other members serve as directors at the Company.
Company Details
- Location
Chandigarh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24231CH1994PLC014820
- Company No.
014820
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
14 Jul 1994
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
What products or services does Mdc Pharmaceuticals Limited offer?
Mdc Pharmaceuticals Limited offers a wide range of products and services, including Common Disease Medicines, Antihistamines, Digestive System Drugs & Medicines, Antacid Drugs, Anti Infective Drugs & Medicines, Antibacterial Drugs, Cosmetics, Hair & Beauty Products, Skin Creams, Antifungal Cream, Ointment & Powder, Anti Acne Drug.
Who are the key members and board of directors at Mdc Pharmaceuticals?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jolly Kashyap  | Company Secretary | 09-Feb-2018 | Current |
| Pramila Devi | CFO | 09-Feb-2018 | Current |
Board Members (8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vir Singh | Director | 26-Feb-2018 | Current |
| Jatinder Wig | Director | 26-Feb-2018 | Current |
| Manisha Sharma | Director | 26-Feb-2018 | Current |
| Harkanwal Bhatia | Director | 26-Feb-2018 | Current |
| Gurmeet Narula | Whole-Time Director | 14-Jul-1994 | Current |
| Ravdeep Matta | Director | 26-Feb-2018 | Current |
Financial Performance of Mdc Pharmaceuticals.
Mdc Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 18.24% increase. The company also saw a substantial improvement in profitability, with a 43.26% increase in profit. The company's net worth moved up by a moderate rise of 9.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mdc Pharmaceuticals?
In 2022, Mdc Pharmaceuticals had a promoter holding of 99.19% and a public holding of 0.82%. The company had 3 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vitamec Healthcare Private LimitedParvinder Gulati is a mutual person
Supreme Bio Tech Pvt LtdGurmeet Narula, Parvinder Gulati and 1 more are mutual person
Spark Multitrade Private LimitedGurmeet Narula is a mutual person
Jasco Labs Private LimitedRavdeep Matta is a mutual person
I M Healthcare Private LimitedParvinder Gulati is a mutual person
Diya Healthcare Private LimitedRavdeep Matta is a mutual person
Charges (Loans)
₹34.65 Cr
₹44.98 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 33.62 Cr
- Axis Bank Limited : 1.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 May 2024 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 29 Apr 2024 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 25 Apr 2024 | Hdfc Bank Limited | ₹2.00 Cr | Open |
| 19 Oct 2023 | Hdfc Bank Limited | ₹5.00 Cr | Open |
| 11 Oct 2023 | Hdfc Bank Limited | ₹11.40 Cr | Open |
How Many Employees Work at Mdc Pharmaceuticals?
Mdc Pharmaceuticals has a workforce of 223 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mdc Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mdc Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.